NovoCure advances in cancer care with device-based therapy, key trial catalysts, and strong financials supporting long-term ...

Google DeepMind and Yale University have created an AI model called C2S-Scale 27B that helped scientists identify cancer ...

In a surprising discovery, MIT scientists found tiny loops in the genomes of dividing cells. Enabled by a high-resolution ...

Rather than working on the surface of cells like some cancer medicines, small molecules are able to slip inside the cell to ...

When cancer progresses on endocrine therapy, the next step is likely either a biopsy to gather tissue for testing or a liquid ...

For 40 years, the United States has recognized October as National Breast Cancer Awareness Month. The month aims to promote ...

Folate, or vitamin B9, is particularly important during times of rapid growth, such as pregnancy and adolescence. Eating ...

T-DXd significantly improved IDFS and reduced the risk of invasive disease or death by 53% compared to T-DM1 in high-risk, HER2-positive breast cancer patients. The trial demonstrated superior ...

A study published in Cancer Discovery finds that combining an epigenetic therapy with an anti-PD-1 antibody, which uses the ...

Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of ...

Endocrine therapy typically slows cell cycle progression by reducing cyclin D1, which partners with CDK4/6 to promote cell ...

Cluster 4/5 was treated with the dual ICI regimen of ipilimumab plus nivolumab. This arm remains open to accrual. Clusters 3, 6, and 7 were excluded from the study. Additional secondary endpoints are ...